title: [Role of Iphosphamide in the treatment of breast cancer]
abstract: Breast cancer is the most frequent solid tumor in women. Predictive and prognostic factors play an important role in the treatment of this cancer. We focused on high risk and heavily pre-treated metastatic breast cancer patients, trying to find the best combination of cytotoxic drugs with high efficacy and low toxicity. Ifosfamide is chemically related to nitrogen mustard and is a synthetic analogue of cyclophosphamide. Ifosfamide has a wide range of antitumor activity. Since ifosfamide as monotherapy has introduced significant tumor reduction in 1(st) line chemotherapy for advanced breast cancer, some studies started with high-dose continuous infusion of ifosfamide,or combined with paclitaxel or vinorelbine. Patients with poor prognosis primary breast cancer treated with high-dose chemotherapy supported by peripheral blood progenitor cell (PBSC) transplantation have lower risk for local relapse and longer disease-free-survival. Ifosfamide working in the mobilization regimen has effective anti-tumor activity while mobilizing sufficient PBPCs in the majority of patients. In combination with other cytotoxics showed to be effective in high-dose protocols.
authors.affiliation: Radiológiai és Onkoterápiás Klinika, Semmelweis Egyetem, Budapest, H1082, Hungary.
authors.forename: Magdolna
authors.initials: M
authors.lastname: Dank
authors.forename: Eva
authors.initials: E
authors.lastname: Pádi
authors.forename: Magdolna
authors.initials: M
authors.lastname: Csepreghy
authors.forename: Ernô
authors.initials: E
authors.lastname: Makó
vernacular_title: Az ifoszfamid szerepe az emlôrák kezelésében.